Health

UK Study: Weight-Loss Jabs Cut NHS Sick Days by 45%

Are weight-loss jabs a groundbreaking public health triumph or a dangerous dependency trap?

Published MAY 16

UK Study: Weight-Loss Jabs Cut NHS Sick Days by 45%

Story

Image credit: Unsplash

The Facts

A study of 1,270 U.K. National Health Service (NHS) patients presented at the European Congress on Obesity in Istanbul this week found that sickness absence fell by 45% among those taking GLP-1 weight-loss injections for nine months, while long-term absences of five days or more dropped by 56%.
Daily Mail
Express
The research, conducted by weight management company Oviva, found that average sick days fell from 1.19 per patient to 0.66, and in-person General Practitioner (GP) appointments dropped by 43%. More than 60% of patients did not contact their GP at all during the study period.
mirror.co.uk
Independent
guardian
Expanding the program to the 3.4 million people in England eligible for weight-loss jabs on the NHS could free up nearly 10 million GP appointments annually, saving the health service around £364 million — equivalent to almost 3% of the GP core budget.
mirror.co.uk
The Telegraph
A separate study of 738 patients prescribed the jabs found emergency visits fell by a quarter. Patients in the Oviva study were severely obese, with an average BMI of 45 at the start, managing at least three conditions including anxiety, high blood pressure and Type 2 diabetes.
Daily Mail
Independent
The Times (UK)
Two Danish studies presented at the same conference found GLP-1 drugs were linked to a 26% reduction in asthma exacerbations and a 14% drop in asthma inhaler use. A separate study found an 18% reduction in acute migraine medication use among 18- to 35-year-olds taking Wegovy.
Daily Mail
guardian
In 2024, the National Institute for Health and Care Excellence recommended the jabs for around 3.4 million people with a BMI of at least 35 but restricted the initial rollout to 220,000 patients over three years.
Express
The Telegraph
The Sun

Sources Split

LEFT

CENTER

RIGHT

ESTAB
CRIT

CENTER

PRO
ESTAB

The Spin

Narrative A

Weight-loss jabs are cutting sick days by 45% and slashing ER visits by 25% — that's a massive win for public health. On top of that, 80% of weight lost comes from fat, not muscle, which demolishes the biggest concern about these drugs. The evidence is stacking up that this treatment genuinely works.

Go Radio on X

PeptideProSource on X

Narrative B

These weight-loss jabs come with a serious catch: stop taking them and the weight comes back heavier than before, making patients dependent on a drug as habit-forming as benzodiazepines. The NHS sick-day reduction only applies to people with obesity-related immune dysfunction, not the general population. Peptides are not a one-size-fits-all fix.

Rob Boyd, Esq on X

PerformanceProtocol on X